SYY
47
-2
PCG
99
2
ACN
70
5
BA
45
-3
IFF
53
2
AIZ
78
2
HES
66
3
GIS
29
3
GS
75
-4
DD
61
4
PWR
71
-3
NWSA
71
-2
INTC
49
16
EW
32
3
RCL
88
-2
AMG
43
3
ALLE
41
-7
XEL
65
-2
KEY
46
-2
EQT
57
-3
SYY
47
-2
PCG
99
2
ACN
70
5
BA
45
-3
IFF
53
2
AIZ
78
2
HES
66
3
GIS
29
3
GS
75
-4
DD
61
4
PWR
71
-3
NWSA
71
-2
INTC
49
16
EW
32
3
RCL
88
-2
AMG
43
3
ALLE
41
-7
XEL
65
-2
KEY
46
-2
EQT
57
-3
Financhill
Back

Rhythm Pharmaceuticals 10K Form

Buy
87

RYTM
Rhythm Pharmaceuticals

Last Price:
59.74
Seasonality Move:
9.98%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RYTM News And Ratings

See the #1 stock for the next 7 days that we like better than RYTM

RYTM Financial Statistics

Sales & Book Value

Annual Sales: $77.43M
Cash Flow: $14.79M
Price / Cash Flow: 0
Annual Sales: $0.18
Price / Book: 350.88

Profitability

EPS (TTM): -4.33000
Net Income (TTM): $-258.91M
Gross Margin: $68.13M
Return on Equity: -208.96%
Return on Assets: -76.55%

Rhythm Pharmaceuticals Earnings Forecast

Key Rhythm Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 6 years for RYTM is 87.99%.
  • The Selling, General & Administrative Expenses for RYTM have been equal to 151.80% of Gross Profit Margin.
  • The Research & Development expenses have been 174.29% of Revenue.
  • The Interest Expense is -7.52% of Operating Income.
  • The Net Earning history of RYTM is -238.52% of Total Revenues.
  • Per Share Earnings over the last 9 years have been positive in 4 years.

Rhythm Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RYTM
CUSIP: 76243J
Website: rhythmtx.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 3.49
Quick Ratio: 3.25

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RYTM Technical Analysis vs Fundamental Analysis

Buy
87
Rhythm Pharmaceuticals (RYTM) is a Buy

Is Rhythm Pharmaceuticals a Buy or a Sell?